{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T03:10:09Z","timestamp":1739157009319,"version":"3.37.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1007\/bf03044937","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T03:42:38Z","timestamp":1244691758000},"page":"467-472","source":"Crossref","is-referenced-by-count":2,"title":["Klinik, Morphologie und Prognose chronischer myelomonozyt\u00e4rer Leuk\u00e4mien","Clinical course, morphological findings and prognosis of CMML"],"prefix":"10.1007","volume":"94","author":[{"given":"Ulrich","family":"Germing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Strupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Meckenstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristoteles","family":"Giagounidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Minning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Aul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03044937_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0145-2126(96)00117-8","volume":"21","author":"C Aul","year":"1997","unstructured":"Aul C, Gattermann N, Germing U, et al. Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia. Leuk Res 1997;21:249\u201353.","journal-title":"Leuk Res"},{"key":"BF03044937_CR2","first-page":"1906","volume":"8","author":"C Aul","year":"1994","unstructured":"Aul C, Gattermann N, Germing U, et al. Risk assessment in primary myelodysplastic syndromes: validation of the D\u00fcsseldorf Score. Leukemia 1994;8:1906\u201313.","journal-title":"Leukemia"},{"key":"BF03044937_CR3","first-page":"52","volume":"6","author":"C Aul","year":"1992","unstructured":"Aul C, Gattermann N, Heyll A, et al. Primary myelodysplastic syndromes (MDS): analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992;6:52\u20139.","journal-title":"Leukemia"},{"key":"BF03044937_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189\u201399.","journal-title":"Br J Haematol"},{"key":"BF03044937_CR5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","volume":"87","author":"JM Bennett","year":"1994","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia group. Br J Haematol 1994;87:746\u201354.","journal-title":"Br J Haematol"},{"key":"BF03044937_CR6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-0609.1989.tb01472.x","volume":"42","author":"MC Canizo del","year":"1989","unstructured":"del Canizo MC, Sanz G, San Miguel JF, et al. Chronic myelomonocytic leukemia \u2014 clinicobiological characteristics: a multivariate analysis in a series of 70 cases. Eur J Haematol 1989;42:466\u201373.","journal-title":"Eur J Haematol"},{"issue":"Suppl 1","key":"BF03044937_CR7","first-page":"P27","volume":"21","author":"J Cervera","year":"1997","unstructured":"Cervera J, Sanz GF, Vallespie T, et al. Does WBC really define two different subtypes of chronic myelomonocytic Leukemia (CMML)? Analysis of a series of 119 patients. Leuk Res 1997;21:Suppl 1:P27.","journal-title":"Leuk Res"},{"key":"BF03044937_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Statist Soc 1972;34:187\u2013200.","journal-title":"J R Statist Soc"},{"key":"BF03044937_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1987.tb06142.x","volume":"65","author":"P Fenaux","year":"1987","unstructured":"Fenaux P, Jouet JP, Zandecki M, et al. Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol 1987;65:101\u20136.","journal-title":"Br J Haematol"},{"key":"BF03044937_CR10","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079\u201388.","journal-title":"Blood"},{"key":"BF03044937_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-4608(91)90235-M","volume":"55","author":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Chronic myelomonocytic leukaemia","year":"1991","unstructured":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Chronic myelomonocytic leukaemia: Single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Cancer Genet Cytogenet 1991;55:57\u201364.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF03044937_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457\u201381.","journal-title":"J Am Statist Assoc"},{"key":"BF03044937_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1987.tb06138.x","volume":"65","author":"H Kerkhofs","year":"1987","unstructured":"Kerkhofs H, Hermanns J, Haak HL, et al. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 1987;65:73\u201381.","journal-title":"Br J Haematol"},{"key":"BF03044937_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10428199309148501","volume":"9","author":"JL Michaux","year":"1993","unstructured":"Michaux JL, Martiat P. Chronic myelomonocytic leukaemia (CMML). A myelodysplastic or myeloproliferative syndrome? Leuk Lymph 1993;9:35\u201341.","journal-title":"Leuk Lymph"},{"issue":"Suppll II","key":"BF03044937_CR15","first-page":"59","volume":"77","author":"T Noesslinger","year":"1998","unstructured":"Noesslinger T, Pfeilst\u00f6cker M, Tuechler H, et al. Dysplastic vs proliferative CMML \u2014 retrospective analysis of 92 patients from a single institution. Ann Hematol 1998;77:Suppll II:S59.","journal-title":"Ann Hematol"},{"key":"BF03044937_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0145-2126(94)00135-W","volume":"19","author":"S Oguma","year":"1995","unstructured":"Oguma S, Yoshida Y, Uduino H, et al. Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a cooperative study based on 838 cases. Leuk Res 1995;19:219\u201327.","journal-title":"Leuk Res"},{"key":"BF03044937_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.1987.tb06858.x","volume":"65","author":"JM Ribera","year":"1987","unstructured":"Ribera JM, Cervantes F, Rozman C. A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria. Br J Haematol 1987;65:307\u201311.","journal-title":"Br J Haematol"},{"key":"BF03044937_CR18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V74.1.395.395","volume":"74","author":"GF Sanz","year":"1989","unstructured":"Sanz GF, Sanz MA, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989;74:395\u2013408.","journal-title":"Blood"},{"key":"BF03044937_CR19","volume-title":"Statistical methods","author":"GW Snedecar","year":"1967","unstructured":"Snedecar GW, Cochran WB. Statistical methods, 6th edn. Ames: Iowa State University Press, 1967.","edition":"6th edn."},{"key":"BF03044937_CR20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V63.3.634.634","volume":"63","author":"P Solal-Celigny","year":"1984","unstructured":"Solal-Celigny P, Desaint B, Herrera A, et al. Chronic myelomoncytic leukemia according to FAB classification: analysis of 35 cases. Blood 1984;63:634\u20138.","journal-title":"Blood"},{"key":"BF03044937_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/bjc.1987.154","volume":"56","author":"AN Stark","year":"1987","unstructured":"Stark AN, Thorogod J, Head C, et al. Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML). Br J Cancer 1987;56:59\u201363.","journal-title":"Br J Cancer"},{"key":"BF03044937_CR22","first-page":"766","volume":"4","author":"AM Storniolo","year":"1990","unstructured":"Storniolo AM, Moloney WC, Rosenthal DS, et al. Chronic myelomonocytic leukemia. Leukemia 1990;4:766\u201370.","journal-title":"Leukemia"},{"key":"BF03044937_CR23","first-page":"499","volume":"7","author":"K Toyama","year":"1993","unstructured":"Toyama K, Ohyashiki K, Yoshida Y, et al. Clinical implication of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993;7:499\u2013508.","journal-title":"Leukemia"},{"key":"BF03044937_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2141.1988.tb04173.x","volume":"68","author":"A Worsley","year":"1988","unstructured":"Worsley A, Oscier DG, Stevens J, et al. Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol 1988;68:17\u201321.","journal-title":"Br J Haematol"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03044937\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T02:45:24Z","timestamp":1739155524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03044937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["BF03044937"],"URL":"https:\/\/doi.org\/10.1007\/bf03044937","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"type":"print","value":"0723-5003"},{"type":"electronic","value":"1615-6722"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}